Related Experiment Videos
Present and future projects of the International Breast Cancer Study Group
A Goldhirsch1, R D Gelber, M Castiglione
1International Breast Cancer Study Group, Coordinating Center, Bern, Switzerland.
Cancer
|August 1, 1994
Summary
The International Breast Cancer Study Group tested combined chemotherapy and endocrine therapy for operable breast cancer. Trials evaluated treatment timing relative to surgery and late-stage chemotherapy introduction.
Area of Science:
- Oncology
- Clinical Trials
- Breast Cancer Research
Background:
- The International Breast Cancer Study Group has a long history of conducting clinical trials since 1978.
- Previous research focused on operable breast cancer treatment strategies.
Purpose of the Study:
- To test biologic hypotheses regarding the combined use of chemotherapy and endocrine therapy in operable breast cancer.
- To evaluate the optimal timing of chemotherapy administration in relation to tumor surgery.
- To assess the efficacy of late introduction of chemotherapy.
Main Methods:
- Conducted nine clinical trials evaluating various treatment regimens.
- Investigated combinations of chemotherapy and endocrine therapy.
- Assessed treatment timing and late-stage chemotherapy introduction.
Main Results:
- Biologic hypotheses concerning combined therapy were tested.
- The impact of chemotherapy timing relative to surgery was evaluated.
- Effectiveness of late chemotherapy introduction was assessed.
Conclusions:
- Ongoing and future trials continue to explore combinations of endocrine therapies and cytotoxic agents.
- The study group's tradition of investigating novel treatment strategies persists.
- Further research is warranted to optimize breast cancer treatment protocols.